Investing Profile

Ali Behbahani

VCInvestor

General Partner at New Enterprise Associates (NEA)

Your Intro Paths to Ali Behbahani

Signal uses Gmail to reveal intro paths. Email content is never read.

Find Ali Behbahani on

Current Investing Position

Investment Range

$2.0M - $50.0M

Sweet Spot

$25.0M

Investments On Record

Current Fund Size

$6.2B

Ali Behbahani is on these Sector & Stage Rankings

Ali Behbahani's Investments On Record (12)

Company	StageDateRound Size	Total Raised
Tune Therapeutics	Series BJan 2025$180M Series ADec 2021$40M	$220M
858 Therapeutics	Series BSep 2024$50M Series ASep 2021$60M	$110M
Co-investors: Clare Ozawa (Versant Ventures)
Amber Therapeutics	Series AJun 2024$100M	$100M
Co-investors: Tiffany Le (New Enterprise Associates (NEA)), Kevin Chu (F-Prime Capital Partners), Caroline Gaynor (Lightstone Ventures)
Nexo Therapeutics	Series AJul 2023$60M	$60M
Co-investors: Carlo Rizzuto (Versant Ventures)
Launchpad Therapeutics	Series ADec 2022$30M	$30M
Co-investors: Alexander Mayweg (Versant Ventures)
Stablix	Series AJun 2021$63M	$63M
Co-investors: Carlo Rizzuto (Versant Ventures)
Monte Rosa Therapeutics	Series CMar 2021$95M Series BSep 2020$96M Series AMay 2020$33M	$220M
Co-investors: Markus Warmuth (Versant Ventures), Alexander Mayweg (Versant Ventures), Chandra Leo (Hbm Partners), Andrew Schiff (Aisling Capital)
Spyglass Ophthalmics	Series BJan 2021$28M Series AMay 2019	$28M
Co-investors: Tak Cheung (New Enterprise Associates (NEA)), Cynthia Yee (Vensana Capital)